digital currency quotes Top stories

OPENAI said that it is working hard to solve the current fault problem.Kweichow Moutai traded 28,300 shares today, with a turnover of 44,312,100 yuan. Kweichow Moutai traded 28,300 shares today, with a turnover of 44,312,100 yuan, accounting for 0.68% of the total turnover of the day. The transaction price was 15.658 yuan, which was the same as the market closing price of 15.658 yuan.18 shares were rated by brokers, and Yuhetian's target increased by 54.72%. On December 11th, a total of 18 shares were rated by brokers, and 6 of them announced their target prices. According to the highest target price, Yuhetian, Steady Medical Care and Fulongma ranked in the top, with increases of 54.72%, 19.96% and 17.62% respectively. Judging from the direction of rating adjustment, the ratings of 12 stocks remain unchanged and 6 stocks are rated for the first time. In addition, one stock attracted the attention of many brokers, and Hagrid Communications was ranked in the top number, with two brokers rating it respectively. Judging from the Wind industry to which the rated stocks are bought, the number of rated stocks for technical hardware and equipment, capital goods and materials II is the largest, with 4, 3 and 2 respectively.

HKEx: It is estimated that the T+1 settlement system will be ready by the end of 2025.Yuncong Technology: "The R&D team of large-scale model agent products is basically dissolved" is all false information. Yuncong Technology said on the interactive platform that the company's R&D team is stable at present, and a rigorous and meticulous hierarchical division of labor system has been established for the research and development of large-scale model related products. The configuration of R&D echelon will be flexibly adjusted according to the continuous evolution of large model technology and the changes of market demand of agent products. The statements of "the No.1 position of the big model algorithm" and "the R&D team of the big model agent product is basically dissolved" mentioned in the question are false information, and the company reserves the right to pursue legal responsibility for this. The company has been unswervingly promoting the research and product development of large-scale model and agent-related technologies.President of STELLANTIS Europe: If you want to avoid EU fines in 2025, you should either increase the sales of electric vehicles or reduce the production of gasoline vehicles.

Market News: South Korean President Yin Xiyue may release a recorded public speech.Hongjiu Fruit: Jiang Zongying, the controlling shareholder and executive director, pledged 21 million H shares of the company. Hongjiu Fruit (06689) announced that the company had learned that Ms. Jiang Zongying, the controlling shareholder and executive director of the company, had pledged the company's shares on December 11, 2024. Because the company failed to return the relevant funds to the subscriber within the time limit stipulated in the termination agreement, Ms. Jiang pledged 21 million H shares of the company to the subscriber as the company's subsequent refund of the relevant funds to the subscriber.CITIC Securities: The resonance between supply and demand of medical beauty accelerates the space expansion, and the difference in operating ability promotes the evolution of the industry structure. CITIC Securities Research Report stated that the medical beauty industry has both medical and consumption attributes, and the medical attribute has strong product-driven characteristics, while the consumption attribute has high operating ability requirements. The medical beauty botulinum toxin track is also affected by the dual attributes of medicine and consumption: 1) The increase in penetration rate, the acceleration of compliance substitution and the extension of indications have brought about high demand for medical beauty botulinum toxin, and with the recent supply expansion, the industry scale has experienced high growth; 2) The iteration of product innovation is slow, brand barriers are created through marketing, doctors are empowered through direct sales, and control is strengthened to enhance product competitiveness. Recently, a variety of medical botulinum toxins in China have been approved, and the promotion of low-priced products is expected to push up the penetration rate, and enterprises with strong operational capabilities will enter the market or promote the evolution of the pattern.